Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MORN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM87B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CD44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAGLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR2682 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAPT1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ORAI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGDS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GMDS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TEAD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPOCK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RORA-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCTN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on